Blog
    Peptide SpotlightFor PatientsSeptember 2, 2026

    Do all peptides work? Evidence and side effects

    Learn how peptides like Semaglutide and MK-677 differ in FDA approval, clinical evidence grades, and potential side effects like nausea or weight regain.

    You have probably seen the hype. Someone on the internet claims that every peptide is a guaranteed win for your health. I hate to be the bearer of bad news, but scientists are still working on this one—turns out the human body is complicated. Who knew?

    While some peptides have stacks of gold-standard evidence, others are still in the 'let's wait and see' category. This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    The Teacher's Pets

    Some peptides have actually put in the work and passed the tests. Semaglutide and Tirzepatide both have an Evidence Grade of A+. They are FDA-approved and have huge trials backing them up.

    For example, the STEP 1 trial showed Semaglutide helped people lose 14.9% of their weight. Tirzepatide went even further in the SURMOUNT-1 trial with 22.5% weight loss. These are the overachievers of the group.

    The 'It Compends' Category

    Then things get a little murky. Take Tesamorelin. It has a Grade A and is FDA-approved, but only for a very specific condition called HIV-associated lipodystrophy.

    If you are looking to use it for general fat loss, there is a catch: that use lacks Phase III evidence. Also, once you stop taking it, the effects completely reverse. It is not exactly a permanent fix.

    The International Mystery Men

    Just because something is popular elsewhere doesn't mean it is proven everywhere.

    • Thymosin Alpha-1: This has an A- grade and is approved in over 35 countries, but it is NOT FDA-approved.
    • Semax: This one has been a standard stroke treatment in Russia for over 25 years. However, it has very limited validation in the West and hasn't been studied in large Western trials.
    • MK-677: Here is a curveball—it is not even a peptide in the strict sense; it is a small-molecule ghrelin mimetic. Despite years of study, it is not FDA-approved and actually failed its trial for Alzheimer's.

    Look Out for the Side Effects

    Even the 'proven' ones aren't all sunshine and rainbows. Semaglutide has a strong signal for nausea, which affected 44% of people in trials. There are even emerging signals for more serious issues like intestinal obstruction.

    Here is the reality check:

    • Weight Regain: For Semaglutide, weight regain after stopping is substantial.
    • Blood Sugar: MK-677 can actually raise your fasting glucose and worsen insulin sensitivity.
    • Cost: Some of these can cost over $1000 a month without insurance.

    This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

    Referenced Peptides

    semaglutidetirzepatidetesamorelinsemaxthymosin alpha 1

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.